Surgery Doctors in Arlington, MA Accepting Medicare

2 Surgery doctors found. Showing 1 - 2

Kathleen Ann Mayzel, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 39 Hathaway Cir, Arlington, MA 02476 Phone: 781-646-8976

Dr. William Francis Flynn, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 22 Mill St, Suite 301, Arlington, MA 02476 Phone: 781-643-6313    Fax: 781-643-6316

News Archive

U.S. adults support restrictions on e-cigarettes based on potential risks

According to the makers of electronic cigarettes, they are new devices that allow users to inhale nicotine but not the toxins of tobacco cigarettes. Advocates hail e-cigarettes as a possible quit-smoking aid.

Celgene announces fiscal 2009 third-quarter results

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $259.8 million, or non-GAAP earnings per diluted share of $0.56 for the quarter ended September 30, 2009. Non-GAAP net income for the third quarter of 2008 was $185.9 million, or non-GAAP earnings per diluted share of $0.40.

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.

Omthera initiates ECLIPSE study for treatment of high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced the initiation of a randomized, open-label, four-way cross-over pharmacokinetics study to evaluate the bioavailability of Epanova, Omthera's lead compound for the treatment of very high triglycerides, in comparison to Lovaza, the leading prescription Omega-3.

ECRI Institute PSO highlights patient safety issue involving cardiac monitoring errors in special E-lert

In a recently released Patient Safety E-lert, the ECRI Institute Patient Safety Organization (PSO) highlights a patient safety issue involving cardiac monitoring of incorrect patients. The issue was brought to ECRI Institute PSO's attention in its analysis of reports submitted by participating healthcare providers.

Read more Medical News

› Verified 9 days ago